News | May 27, 2021
Cadila Healthcare posts consolidated PAT of Rs. 679 Cr
Cadila Healthcare has reported total income of Rs.15139.4 crores FY 2020-21
Cadila Healthcare has reported total income of Rs.15139.4 crores FY 2020-21
The company reported net profit for FY21 at Rs. 2,903.8 crore, lower by 23% over last year
Revenue from operations for the year ended March 31, 2021 is ?2,239 crore
Posaconazole is a triazole antifungal agent indicated for treating mucormycosis patients
It posted net profit of Rs.188.77 crores for the period ended March 31, 2020.
The turnover of its NPNC Formulations Division (IKKT Undertaking) for FY 2020-2021 is Rs.21.33 Cr
The antibody cocktail is to be administered for the treatment of mild to moderate COVID-19
This marks Glenmark's first synthetic decapeptide injectable approval
BALflu is approved by DCGI for emergency use for the treatment of COVID-19
The company has reported total income of Rs.826.40 crores for FY 2020-21
Subscribe To Our Newsletter & Stay Updated
